Effect of dietary supplementation with branched-chain amino acids on spontaneous motor activity and muscle function in β,β'-iminodipropionitrile-treated rats: A model for motorneuropathy

Physiology and Behavior

Volumn 62, Issue 3, 1997, Pages 453-462

  Kitahara, Yoshiro ^a   Maki, Toshio ^a   Torii, Kunio ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

Branched chain amino acids; Muscle function; Muscle strength; Progressive muscle weakness; , ' Iminodipropionitrile

Indexed keywords

3,3' IMINODIPROPIONITRILE; BRANCHED CHAIN AMINO ACID; CREATINE KINASE; CREATININE; DRINKING WATER; ISOLEUCINE; LEUCINE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; ENERGY METABOLISM; HISTOPATHOLOGY; MALE; MOTOR ACTIVITY; MOTOR NEUROPATHY; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR DYSTROPHY; RAT; TREADMILL;

EID: 0030962777     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00154-6     Document Type: Article

References (33)

1. Abrass C. K. Glomerulonephritis in the elderly. Am. J. Nephrol. 5:1985;409-418.
2. Boroujerdi M., Mattocks A. M. Metabolism of creatinine in vivo. Clin. Chem. 29:1983;1363-1366.
3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Brooks B. R., Sufit R. L., DePaul R., Tan Y. D., Sanjak M., Robbins J. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Rowland L. P. Advances in neurology. Amyotrophic lateral sclerosis and other motor neuron diseases. 56:1991;521-546 Raven Press, New York.
5. Cadet J. L. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: Behavioral and biochemical pharmacology. Neurosci. Biobehav. Rev. 13:1989;39-45.
6. Chou S. M., Hartmann H. A. Axonal lesions and waltzing syndrome after IDPN administration in rats. Acta Neuropathol. 3:1964;428-450.
7. Clark A. W., Griffin J. W., Price D. L. The axonal pathology in chronic IDPN intoxication. J. Neuropathol. Exp. Neurol. 39:1980;42-55.
8. Collard J-F., Côté F., Julien J-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
9. Crim M. C., Calloway D. H., Margen S. Creatine metabolism in men: creatinine pool size and turnover in relation to creatine intake. J. Nutr. 106:1976;371-381.
10. Delio D., Fioli M. G., Lowndes H. E. Motor unit function during evolution of proximal axonal swellings. J. Neurol. Sci. 109:1992;30-40.
11. Gold B. G. The pathophysiology of proximal neurofilamentous giant axonal swellings: Implications for the pathogenesis of amyotrophic lateral sclerosis. Toxicology. 46:1987;125-139.
12. Griffin J. W., Hoffman P. N., Clark A. W., Carroll P. T., Price D. L. Slow axonal transport of neurofilament proteins: Impairment by β , β ′-iminodipropionitrile administration. Science. 202:1978;633-635.
13. Höfinger E., Le Quense P. M., Gajree T. Conduction velocity in nerve fibres with axonal atrophy due to chronic β , β ′-iminodipropionitrile (IDPN). J. Neurol. Sci. 53:1982;159-167.
14. Ivens I. Neurotoxicity testing during long-term studies. Neurotoxicol. Teratol. 12:1990;637-641.
15. Kitahara Y., Maki T., Torii K. Development of degenerative muscle weakness by chronic administration of β , β ′ iminodipropionitrile in the drinking water to rats: A model for motorneuropathy. Physiol. Behav. 62:1997;443-451.
16. Llorens J., Demêmes D., Sans A. The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells. Toxicol. Appl. Pharmacol. 123:1993;199-210.
17. Louard R. J., Barrett E. J., Gelfand R. A. Overnight branched-chain amino acid infusion causes sustained suppression of muscle proteolysis. Metabolism. 44:1995;424-429.
18. MacLean D. A., Spriet L. L., Hultman E., Graham T. E. Plasma and muscle amino acid and ammonia responses during prolonged exercise in humans. J. Appl. Physiol. 70:1991;2095-2103.
19. McDowell H. E., Christie G. R., Stenhouse G., Hundal H. S. Leucine activates system A amino acid transport in L6 skeletal muscle cells. Am. J. Physiol. 269:1995;C1287-C1294.
20. Miller A. T., Blyth C. S. Estimation of lean body mass and body fat from basal oxygen consumption and creatinine excretion. J. Appl. Physiol. 5:1952;73-78.
21. Mitsumoto H., Hanson M. R., Chad D. A. Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch. Neurol. 45:1988;189-202.
22. Moser V. C., Boyes W. K. Prolonged neurobehavioral and visual effects of short-term exposure to 3,3′-iminodipropionitrile (IDPN) in rats. Fundam. Appl. Toxicol. 21:1993;277-290.
23. Nishiyama K., Kwak S., Murayama S., Watanabe M., Goto J., Asayama K., Kanazawa I. Increased Cu/Mn superoxide dismutase-like immunoreactivity in the swollen axons of rats intoxicated chronically with beta,beta′-iminodipropionitrile. Neurosci. Lett. 194:1995;205-208.
24. Odessey R., Goldberg A. L. Oxidation of leucine by rat skeletal muscle. Am. J. Physiol. 223:1972;1376-1383.
25. Plaitakis A., Berl S., Yahr M. D. Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann. Neurol. 15:1984;144-153.
26. Plaitakis A., Caroscio J. T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 22:1987;575-579.
27. Plaitakis A., Smith J., Mandeli J., Yahr M. D. Pilot trial of branched-chain amino acids in amyotrophic lateral sclerosis. Lancet. 1:1988;1015-1018.
28. Tischler M. E., Desautels M., Goldberg A. L. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J. Biol. Chem. 257:1982;1613-1621.
29. Tilney F., Kubie L. S. Behavior in its relation to the development of the brain. Part I. Bull. Neurol. Inst. NY. 1:1931;229-313.
30. Torii K., Mawatari K., Kawada T., Mori M., Masaki H., Yugari Y. Effects of alanine and glutamine intubation on ethanol metabolism and spontaneous motor activity in rats receiving ethanol loading. Pharma Medica. 5:1987;81-87.
31. Verger P. H., Aymard P., Cynobert L., Anton G., Luigi R. Effects of administration of branched-chain amino acids vs. glucose during acute exercise in the rat. Physiol. Behav. 55:1994;523-526.
32. Wagenmakers A. J. M., Beckers E. J., Brouns F., Kuipers H., Soeters P. B., van der Vusse G. J., Saris W. H. M. Carbohydrate supplementation, glycogen depletion, and amino acid metabolism during exercise. Am. J. Physiol. 260:1991;E883-E890.
33. Wolff G., Kunze E., Rodden A., Oepen H. Loss of auditory startle-reflex in the iminodipropionitrile (IDPN) treated rat. Life Sci. 20:1977;1163-1166.